- $491.54m
- $391.49m
- $445.25m
- 32
- 57
- 52
- 45
Annual income statement for Sharecare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 340 | 329 | 413 | 442 | 445 |
| Cost of Revenue | |||||
| Gross Profit | 160 | 168 | 210 | 204 | 191 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 349 | 346 | 499 | 582 | 581 |
| Operating Profit | -9.88 | -17.4 | -86.6 | -139 | -136 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -39.2 | -58.1 | -87.2 | -120 | -130 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -39.4 | -56.6 | -85.1 | -119 | -130 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -40 | -60.8 | -85 | -119 | -128 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -40 | -60.8 | -85 | -119 | -128 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.172 | -0.268 | -0.223 | -0.305 | -0.292 |